Kura Oncology Inc (KURA) Event Aug. 03, 2022, 00:00 UTC (51% Neutral) KURA ONCOLOGY, INC. (KURA) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:45 a.m. 🏢 Kura Oncology Inc (KURA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-03 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-64.36M $-67.22M $2.87M +4.26% ↗️ Total Assets $534.05M $471.43M $62.63M +13.28% 📈 Total Liabilities $27.44M $21.93M $5.51M +25.11% 📉 Stockholders' Equity $558.55M $-366.86M $925.41M +252.25% 📈 R&D Expense $41.40M $45.17M $-3.77M -8.35% 📈 Earningspersharebasic $-0.97 $-1.01 $0.04 +3.96% ➡️ Earningspersharediluted $-0.97 $-1.01 $0.04 +3.96% ➡️ 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Kura Oncology Inc (KURA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document